Novel Mutation in an Iranian Family with 17-β Hydroxysteroid Dehydrogenase Type 3 Deficiency

被引：0
|
作者：
Saffari, Fatemeh [1 ]
Homaei, Ali [2 ]
机构：
[1] Qazvin Univ Med Sci, Res Inst Prevent Noncommunicable Dis, Children Growth Res Ctr, Qazvin, Iran
[2] Shahid Beheshti Med Univ, Tehran, Iran
来源：
HORMONE RESEARCH IN PAEDIATRICS | 2021年 / 94卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2-433
引用
收藏
页码：394 / 394
页数：1
相关论文
共 50 条
  • [41] 46,XY disorder of sex development (DSD) due to 17β-hydroxysteroid dehydrogenase type 3 deficiency
    Mendonca, Berenice B.
    Gomes, Nathalia Lisboa
    Costa, Elaine M. F.
    Inacio, Marlene
    Martin, Regina M.
    Nishi, Mirian Y.
    Carvalho, Filomena Marino
    Tibor, Francisco Denes
    Domenice, Sorahia
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2017, 165 : 79 - 85
  • [42] Early and late diagnoses of 17β-Hydroxysteroid dehydrogenase type-3 deficiency in two unrelated patients
    Manyas, Hayrullah
    Filibeli, Berna Eroglu
    Ayranci, Ilkay
    Guvenc, Merve S.
    Dundar, Bumin N.
    Catli, Gonul
    ANDROLOGIA, 2021, 53 (06)
  • [43] Novel inhibitors of 17β-hydroxysteroid dehydrogenase type 1:: Templates for design
    Allan, Gillian M.
    Vicker, Nigel
    Lawrence, Harshani R.
    Tutill, Helena J.
    Day, Joanna M.
    Huchet, Marion
    Ferrandis, Eric
    Reed, Michael J.
    Purohit, Atul
    Potter, Barry V. L.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (08) : 4438 - 4456
  • [44] 17-β-hydroxysteroid dehydrogenase type 1:: computational design of active site inhibitors targeted to the Rossmann fold
    Brown, WM
    Metzger, LE
    Barlow, JP
    Hunsaker, LA
    Deck, LM
    Royer, RE
    Vander Jagt, DL
    CHEMICO-BIOLOGICAL INTERACTIONS, 2003, 143 : 481 - 491
  • [45] Coumarins as novel 17β-hydroxysteroid dehydrogenase type 3 inhibitors for potential treatment of prostate cancer
    Harada, Koichiro
    Kubo, Hideki
    Tomigahara, Yoshitaka
    Nishioka, Kazuhiko
    Takahashi, Junya
    Momose, Mio
    Inoue, Shinichi
    Kojima, Atsuyuki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (01) : 272 - 275
  • [46] Genetic and biochemical diagnosis of 17β-hydroxysteroid dehydrogenase deficiency
    不详
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 (10): : 672 - 672
  • [47] 17β-Hydroxysteroid dehydrogenase type 3 deficiency as a result of a homozygous 7 base pair deletion in 17βHSD3 gene
    Alikasifoglu, Ayfer
    Hiort, Olaf
    Gonc, Nazli
    Demirbilek, Huseyin
    Isik, Emregul
    Kandemir, Nurgun
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2012, 25 (5-6): : 561 - 563
  • [48] Male pseuclohermaphroditism due to 17 β-hydroxysteroid dehydrogenase deficiency
    Bel, J
    Mainou, A
    Blanco, JA
    Bilbao, JR
    MEDICINA CLINICA, 2003, 120 (20): : 795 - 795
  • [49] Morpholylureas are a new class of potent and selective inhibitors of the type 5 17-β-hydroxysteroid dehydrogenase (AKR1C3)
    Flanagan, Jack U.
    Atwell, Graham J.
    Heinrich, Daniel M.
    Brooke, Darby G.
    Silva, Shevan
    Rigoreau, Laurent J. M.
    Trivier, Elisabeth
    Turnbull, Andrew P.
    Raynham, Tony
    Jamieson, Stephen M. F.
    Denny, William A.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (03) : 967 - 977
  • [50] A novel succinate dehydrogenase type B mutation in an Iranian family. Its genetic and clinical evaluation
    Ghazi A.A.
    Khah A.M.
    Kamani F.
    Zare K.
    Sadeghipour A.
    Hedayati M.
    Yeganeh M.Z.
    Cranston T.
    Grossman A.
    Hormones, 2014, 13 (4) : 568 - 573
12345